Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
$ 18.695 0.245 (1.33%) Market Cap: 21.04 Bil Enterprise Value: 37.43 Bil PE Ratio: 0 PB Ratio: 3.30 GF Score: 59/100

Teva Pharmaceutical Industries Ltd at Barclays Global Healthcare Conference Transcript

Mar 14, 2023 / 02:15PM GMT
Release Date Price: $8.91 (-0.34%)
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director

Good morning, everyone. My name is Balaji Prasad. I'm the senior analyst for the Barclays Specialty Pharmaceuticals coverage. For the next session of the day at the Barclays Annual Healthcare Conference, I have the pleasure of hosting Teva and Eli Kalif, the Chief Financial Officer from Teva. Eli, thank you so much for joining us today. It's a pleasure to have you here.

Eliyahu Sharon Kalif
Teva Pharmaceutical Industries Limited - Executive VP & CFO

Thank you for having me. Really excited to be here.

Balaji V. Prasad
Barclays Bank PLC, Research Division - Director

Yes. It's a very interesting phase for Teva now with the CEO change and everything else. But considering that you had your earnings call recently, why don't you start with a couple of recaps from the earnings call and then we can get into Q&A.

Eliyahu Sharon Kalif
Teva Pharmaceutical Industries Limited - Executive VP & CFO

Yes. So

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot